skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

New product launches and label expansions will drive growth despite genericization of key brands

What’s the overall outlook for the multiple myeloma (MM) market? Positive or negative?

The answer is positive! Datamonitor Healthcare predicts that the extended indications for key MM drugs will lead to considerable uptake across the treatment algorithm, which will strongly contribute to the total sales of the overall MM market.


Highlights from this report include:

  • 20 year forecasts of the incidence and prevalence of MM

  • Overview of the current competitive landscape in MM

  • Patient-based forecast of the MM market over 2015–24

Read also


Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: